Parkinson Disease
📧 Sign up to get email alerts when something new happens for Parkinson Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2014-05-28Clinical Trial Update: An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease [Phase 2]
Phase 2 pharmacokinetic and pharmacodynamic evaluation of the investigational drug AP09004 in patients with Parkinson's disease has complete…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa [Phase 2]
This update reports the completion of a Phase 2 trial evaluating istradefylline (KW-6002) as add-on therapy to levodopa in Parkinson's disea…
-
CLINICAL_TRIALS trial_result · 2014-05-23Clinical Trial Update: A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 3]
A Phase 3 study evaluating SPM 962 in advanced Parkinson's disease, comparing against placebo and ropinirole, has completed with results pos…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease [Phase 3]
Phase 3 two-part trial (306A/306B) evaluated droxidopa for neurogenic orthostatic hypotension in Parkinson's disease; the study completed an…
-
CLINICAL_TRIALS trial_result · 2014-05-20Clinical Trial Update: Anesthesia for Deep Brain Stimulation [Phase 4]
A Phase 4 clinical trial evaluating anesthesia approaches for deep brain stimulation in Parkinson's disease has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Development of Imaging, Clinical and Biochemical Bio-Markers for Parkinson's Disease [Phase 2]
A Phase 2 study evaluating imaging, clinical and biochemical biomarkers for Parkinson's disease and Parkinsonian syndrome has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-09Clinical Trial Update: Imaging and Genetic Biomarkers of Parkinson Disease (PD) Onset and Progression in High-risk Families [Phase 2]
Phase 2 clinical trial update examining imaging and genetic biomarkers for onset and progression of Parkinson disease in high-risk families.…
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Relaxation Guided Imagery for Treatment of Parkinson's Disease [EARLY_Phase 1]
An early-phase 1 trial evaluating relaxation guided imagery as a treatment for Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-08Clinical Trial Update: Repetitive Transcranial Magnetic Stimulation (TMS) for Progressive Supranuclear Palsy and Corticobasal Degeneration
This clinical trial update notes that a study evaluating repetitive transcranial magnetic stimulation (TMS) for progressive supranuclear pal…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Evaluation of 123-I Iodobenzovesamicol (IBVM) and SPECT Imaging of Healthy Subjects and Patients With Alzheimer Disease [Phase 2]
Phase 2 study evaluating 123-I Iodobenzovesamicol (IBVM) with SPECT imaging in healthy subjects and patients with Alzheimer's disease and Pa…
-
CLINICAL_TRIALS trial_result · 2014-05-07Clinical Trial Update: Evaluation of 5-[123I]-A-85380 and SPECT Imaging in Individuals With Parkinsons Disease [Phase 2]
A Phase 2 trial evaluated 5-[123I]-A-85380 with SPECT imaging for Parkinson disease; the study has completed.
-
CLINICAL_TRIALS trial_result · 2014-05-05Clinical Trial Update: Famotidine for Levodopa-induced Dyskinesia in PD [Phase 2]
Phase 2 trial evaluating famotidine for levodopa-induced dyskinesia in Parkinson's disease has completed.
-
CLINICAL_TRIALS trial_result · 2014-04-21Clinical Trial Update: Effects of Mental Practice in Gait of Individuals With Parkinson Disease: Randomized Clinical Trial [NA]
This update reports the completion of a randomized clinical trial evaluating whether mental practice improves gait in individuals with Parki…
-
CLINICAL_TRIALS trial_result · 2014-04-16Clinical Trial Update: The Effects of Supplementing Tyrosine on Blood Pressure in Parkinson's Disease [Phase 1, Phase 2]
A completed Phase 1/2 clinical trial evaluating the effects of L-tyrosine supplementation on blood pressure in individuals with Parkinson's …
-
CLINICAL_TRIALS trial_result · 2014-04-14Clinical Trial Update: Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease [NA]
A completed clinical trial evaluated whether eradicating Helicobacter pylori improves levodopa response, motor outcomes, and quality of life…
-
CLINICAL_TRIALS trial_result · 2014-04-07Clinical Trial Update: A Phase 4, Open-label Study to Assess the Feasibility and Efficacy on Motor and Non-motor Symptoms of Switching From Pramipexole or Ropinirole to Rotigotine Transdermal Patch in Subjects With Advanced Idiopathic Parkinson's Disease [Phase 4]
Phase 4 open-label trial assessing feasibility and efficacy of switching advanced Parkinson's disease patients from pramipexole or ropinirol…
-
CLINICAL_TRIALS trial_result · 2014-04-02Clinical Trial Update: Determination of Muscle Strength in Parkinsonian Patients Through the Use of an Isokinetic Dynamometer
This clinical trial completed an assessment of muscle strength in Parkinson's disease patients using an isokinetic dynamometer. The update c…
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Crossover Versus Stabilometric Platform in Parkinson's Disease
This clinical trial update reports the completion of a crossover versus stabilometric platform study in Parkinson's disease.
-
CLINICAL_TRIALS trial_result · 2014-03-28Clinical Trial Update: Hallux Mobilization in Patients With Parkinson's Disease
This clinical trial update reports that the study evaluating hallux mobilization in patients with Parkinson disease has completed. The docum…
-
CLINICAL_TRIALS trial_result · 2014-03-24Clinical Trial Update: Study On Utilization Of Cabergoline For Compliance With Risk Minimization Activities (SUCRE)
Pfizer-sponsored study evaluated cabergoline for compliance with risk minimization activities. The trial, involving Parkinson's disease and …
-
CLINICAL_TRIALS trial_result · 2014-03-21Clinical Trial Update: Structured Physical Activity for Sleep Quality and Daytime Sleepiness in Patients With Parkinson's Disease [NA]
A Northwestern University trial evaluating structured physical activity to improve sleep quality and daytime sleepiness in Parkinson's disea…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Dose-ranging Study for SPM 962 in Parkinson's Disease Patients [Phase 2]
A Phase 2 dose-ranging trial of SPM 962 in Parkinson's disease has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients [Phase 2, Phase 3]
A placebo-controlled study of SPM 962 in patients with Parkinson's disease completed its Phase 2/Phase 3 program. Results were posted in 201…
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients [Phase 2]
Phase 2 dose-finding study of SPM 962 for advanced Parkinson's disease has completed and results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-03-19Clinical Trial Update: A Long-Term Extension Trial From Late Phase II of SPM 962 in Advanced Parkinson's Disease Patients [Phase 2]
A long-term extension study stemming from late-phase II testing of SPM 962 in advanced Parkinson's disease; results were posted in 2014.